Bexion Pharmaceuticals

📍 Covington, United States🗓 Founded 2006👥 27 employees💰 Last funded Jul 2018
Biotechnology🌐 bexionpharma.com
Website LinkedIn
Poised to Deliver Breakthroughs in Oncology and CNS Bexion Pharmaceuticals is a mid-stage clinical company developing life-changing treatments in Oncology and CNS. The company’s lead compound, BXQ-350, is a novel S1P modulator. With our highly experienced biotech leadership team and expertise in Oncology, we are urgently progressing our pipeline to develop life-changing oncology therapies on our path to becoming a leading biotech/pharmaceutical company. To learn more about Bexion Pharmaceuticals, please visit Bexionpharma.com or call (859) 446-7386.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2006
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Bexion Pharmaceuticals?
Bexion Pharmaceuticals has 1 investor on record on gritt.io.
When did Bexion Pharmaceuticals last raise funding?
The most recent investment in Bexion Pharmaceuticals recorded on gritt.io was in July 2018.
When was Bexion Pharmaceuticals founded?
Bexion Pharmaceuticals was founded in 2006.
What industry is Bexion Pharmaceuticals in?
Bexion Pharmaceuticals operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Bexion Pharmaceuticals based?
Bexion Pharmaceuticals is headquartered in Covington, United States.